FABP4 and metabolic dysfunction-associated steatotic liver disease: In addition, SREBP1 and FABP4 mRNA expression are associated with the expression of genes participating in lipid storage, hepatic steatosis, hepatic lipogenesis, and NAFLD pathogenesis [97].